These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Azapirones: an alternative to benzodiazepines for anxiety. Cadieux RJ Am Fam Physician; 1996 May; 53(7):2349-53. PubMed ID: 8638511 [TBL] [Abstract][Full Text] [Related]
24. Panic disorder: the potential role of serotonin reuptake inhibitors. Sheehan DV; Zak JP; Miller JA; Fanous BS J Clin Psychiatry; 1988 Aug; 49 Suppl():30-6. PubMed ID: 3045109 [TBL] [Abstract][Full Text] [Related]
25. Serotonin function and human anxiety disorders. Charney DS; Woods SW; Krystal JH; Heninger GR Ann N Y Acad Sci; 1990; 600():558-72; discussion 572-3. PubMed ID: 2252335 [No Abstract] [Full Text] [Related]
26. Animal models for anxiety and response to serotonergic drugs. Broekkamp CL; Berendsen HH; Jenck F; Van Delft AM Psychopathology; 1989; 22 Suppl 1():2-12. PubMed ID: 2567038 [TBL] [Abstract][Full Text] [Related]
27. Influence of inflammatory nociception on the anxiolytic-like effect of diazepam and buspirone in rats. Fernández-Guasti A; Reyes R; Martínez-Mota L; López-Muñoz FJ Psychopharmacology (Berl); 2005 Jul; 180(3):399-407. PubMed ID: 15719217 [TBL] [Abstract][Full Text] [Related]
28. How to manage anxious patients who are depressed. Sussman N J Clin Psychiatry; 1993 May; 54 Suppl():8-16; discussion 17-20. PubMed ID: 8099581 [TBL] [Abstract][Full Text] [Related]
29. Antidepressant-like properties of some serotonin receptor ligands and calcium channel antagonists measured with the forced swimming test in mice. Biała G Pol J Pharmacol; 1998; 50(2):117-24. PubMed ID: 9798263 [TBL] [Abstract][Full Text] [Related]
30. Pharmacologic treatments effective in both generalized anxiety disorder and major depressive disorder: clinical and theoretical implications. Casacalenda N; Boulenger JP Can J Psychiatry; 1998 Sep; 43(7):722-30. PubMed ID: 9773222 [TBL] [Abstract][Full Text] [Related]
32. The new generation of serotonergic anxiolytics: possible clinical roles. Eison MS Psychopathology; 1989; 22 Suppl 1():13-20. PubMed ID: 2567037 [TBL] [Abstract][Full Text] [Related]
33. Buspirone and diazepam in anxiety: a controlled study. Rickels K; Weisman K; Norstad N; Singer M; Stoltz D; Brown A; Danton J J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):81-6. PubMed ID: 6130078 [TBL] [Abstract][Full Text] [Related]
34. Serotonin: a common neurobiologic substrate in anxiety and depression. Eison MS J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):26S-30S. PubMed ID: 2198299 [TBL] [Abstract][Full Text] [Related]
35. Efficacy of the 5-HT1A agonist, buspirone hydrochloride, in migraineurs with anxiety: a randomized, prospective, parallel group, double-blind, placebo-controlled study. Lee ST; Park JH; Kim M Headache; 2005 Sep; 45(8):1004-11. PubMed ID: 16109114 [TBL] [Abstract][Full Text] [Related]
36. A comparison of buspirone, diazepam, and placebo in patients with chronic anxiety states. Olajide D; Lader M J Clin Psychopharmacol; 1987 Jun; 7(3):148-52. PubMed ID: 2885344 [TBL] [Abstract][Full Text] [Related]
37. Mixed depression and anxiety: serotonin1A receptors as a common pharmacologic link. Stahl SM J Clin Psychiatry; 1997; 58 Suppl 8():20-6. PubMed ID: 9236732 [TBL] [Abstract][Full Text] [Related]
38. [Mechanism of action of antidepressants and therapeutic perspectives]. Bourin M; David DJ; Jolliet P; Gardier A Therapie; 2002; 57(4):385-96. PubMed ID: 12422559 [TBL] [Abstract][Full Text] [Related]